Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gregory A Daniels
Durability of Responses in Patients With Metastatic Renal Cell Carcinoma Treated With High Dose Interleukin-2 (HD IL-2)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features
PLoS ONE
Multidisciplinary
Disparities in the Treatment of Patients With IL-2 for Metastatic Renal Cell Carcinoma
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Intravenous Interleukin-2 in Patients Over 65 With Metastatic Renal Carcinoma
British Journal of Cancer
Cancer Research
Oncology
A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
Sorafenib With Interleukin-2 vs Sorafenib Alone in Metastatic Renal Cell Carcinoma: The ROSORC Trial
British Journal of Cancer
Cancer Research
Oncology
Two Randomised Phase II Trials of Subcutaneous Interleukin-2 and Histamine Dihydrochloride in Patients With Metastatic Renal Cell Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Perioperative Immunomodulation With Interleukin-2 in Patients With Renal Cell Carcinoma: Results of a Controlled Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
